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Abstract 
Fatty acids play essential roles in the growth and metastasis of cancer cells. To facilitate their avid 
growth and proliferation, cancer cells not only alter the fatty acid synthesis and metabolism 
intracellularly and extracellularly, but also in the macroenvironment via direct and indirect 
pathways. This thesis reports that by using Raman micro-spectroscopy, an increase in the 
production of polyunsaturated fatty acids (PUFAs) was identified in both cancerous and normal 
appearing breast tissue obtained from breast cancer patients and tumor-bearing rats. By minimizing 
confounding effects from mixed chemicals and optimizing the signal-to-noise ratio of Raman 
spectra, a large-scale transition from monounsaturated fatty acids to PUFAs was observed in the 
tumor while only a small subset of fatty acids transitioned to PUFAs in the tumor micro- and 
macroenvironment. These findings demonstrate the power of this spectroscopic analysis, and may 
provide new insights into the macroenvironmental regulations in breast cancer.  
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1   Introduction  
1.1   Tumor micro- and macroenvironment in breast cancer 
Despite the rapid technological advance in cancer diagnosis and treatment, breast cancer 
continues to persist as the second most common cancer, as well as the second most common cause 
of cancer-related deaths among women in the United States (1). There remains a need for a better 
understanding of breast cancer development and for more effective diagnostic and therapeutic 
strategies that can help to reduce the burden of breast cancer.   
Among the best-studied areas of breast cancer is the alterations that occur in cancer cells. 
Despite their genotypic diversity, it has been shown that at least three pronounced phenotypes exist 
in all aggressive cancers. One of them is related to the Warburg effect, which describes the high-
rate consumption of glucose and production of lactic acid within cancer cells even under aerobic 
conditions (2,3). A second hallmark is increased protein synthesis and more active DNA synthesis 
driven by vigorous and constant proliferation and dissemination (4). A third hallmark is an 
increased de novo fatty acid synthesis, which is critically related to energy metabolism, cell 
membrane formation, and signaling events (5). 
Less well studied, although supported by a wide range of imaging and genetic studies, is the 
active interaction between the tumor microenvironment and the tumor (6,7). Stromal cells, 
including fibroblasts (8), macrophages (9), adipocytes (10), and vascular cells (11), have been 
shown to be recruited to the tumor sites to generate a tumorigenic microenvironment. It also has 
been shown that non-cellular components in the tumor microenvironment, such as the extracellular 
matrix (ECM), have direct and indirect impacts on cancer and stromal cells, thereby facilitating 
migration and invasion (12–14).  It is now widely acknowledged that the interactions between 
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tumor cells and their local environment play important roles in cancer development (3,6,15,16). 
These studies have provided invaluable insights into the development, diagnosis, and treatment of 
cancer (17–19). 
More recently, however, scientists and clinicians have increasingly begun to expand their 
investigations from the local tumor microenvironment to a more global tissue macroenvironment 
(tissue at a larger distance from the primary tumor), appreciating the active participation of a 
complex array of host factors in tumor progression (20,21). As cancer cells are vigorously and 
constantly replicating and disseminating themselves, they impose a larger requirement to maintain 
their viability compared to non-proliferating (differentiated) cells (22). These avidly proliferating 
cells have to create a tumor-supportive environment locally and systematically to meet the 
demanding requirements of resources and also protect themselves from possible immune attacks. 
It has been shown that the macroenvironmental regulation of cancer occurs at the genetic, 
proteomic, and metabolic levels to elicit carcinogenesis, metastasis, and progression (20,23,24). 
For instance, previous reports identified genetic alterations not only in the stromal cells close to 
breast carcinomas, but also in the tumor-free and normal appearing skin of the patients with breast 
cancer (20,25). Understanding how tumors interact with the macroenvironment is likely to have a 
major impact on our understanding of the complex mechanisms underlying cancer development, 
as well as establish links between cancer and metabolic diseases such as obesity and diabetes. 
Moreover, these new insights could also contribute to new therapeutic targets for cancer in general, 
and breast cancer in particular.  
Despite such importance, the quantitative evaluation of changes in tissues remote from 
tumor sites remains largely unexplored. There continues to be a need for quantitative 
characterization of the tumor macroenvironment for potential use in biological and clinical studies 
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that are devoted to treating cancer-related metabolic disease and developing macroenvironment-
targeted therapeutic treatments.  
1.2   Lipid metabolism in breast cancer 
As noted, there is growing evidence that the metabolism of cancer cells is distinct from that 
of cells in normal tissue due to their different metabolic requirements (22,26). Survival of a 
mammalian organism highly depends on the precise control of individual cell proliferation and 
strict regulation of nutrient up-take. In normal differentiated mammalian cells, proliferation is only 
possible when exposed to specific growth factors and thus aberrant individual cell proliferation is 
prevented. In contrast, such growth factor dependence does not exist for cancer cells. The ultimate 
goal of cancer cells is to survive, grow, and proliferate irrespective of whether they are endangering 
the survival of their host. In order to meet the usual demands of such rapid growth and proliferation 
of these cancer cells, several significant signaling pathways are altered to activate the uptake and 
metabolism of nutrients that fuel cell growth and promote cell dissemination.  
Among all the metabolic pathways, lipid metabolism has recently gained much prominence 
for its diverse roles in cell membrane formation, energy storage, and signaling pathways (27). The 
term lipid includes a diverse group of hydrophobic compounds that are mostly composed of fatty 
acids bound to a polyalcohol with an ester bond. Some of the lipids are major constituents of all 
biological membranes, such as phospholycerides, sterols, and sphingolipids. Triacylglycerol is 
another form of lipids and an important substrate for energy metabolism. In addition, some of the 
lipids, such as cholesterol, serve as signaling molecules in the form of messengers and hormones 
to sustain homeostasis. 
Given the important physiological roles of lipids at both cellular and organismal levels, it is 
not surprising to see that alterations in lipid metabolism profoundly affect the regulation of 
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proliferation, differentiation, apoptosis, autophagy, inflammation, motility, and membrane 
homeostasis (28). One of the first and most important breakthroughs of studies on lipid metabolism 
in cancer is the discovery of de novo lipogenesis in cancer cells (29). Most normal cells tend to 
use exogenously derived (dietary) fatty acids in a well-nourished environment. However, 
irrespective of the levels of circulating lipids, cancer cells tend to resort to endogenously 
synthesized fatty acids, which normally is only very active during embryogenesis and in fetal lungs 
of healthy individuals. Such upregulation of fatty acid synthase is not only a secondary 
consequence of carcinogenesis, but more importantly, it is directly selected for the growth and 
survival advantage it provides via multiple mechanisms (30).  
Increased cholesterol biosynthesis is another important event in dysregulated lipid 
metabolism induced by breast cancer. Cholesterol is an important constituent of biological 
membranes due to its ability to modulate the fluidity of the lipid bilayer and facilitate the signaling 
events at the membrane (27). In most cells, free cholesterol is maintained at a relatively constant 
level by several homeostatic processes (31). In contrast, such homeostasis is disrupted in avidly 
proliferating breast cancer cells. It has been difficult, however, to understand how this is enabled 
by cancer cells, given the complexity and redundancy of the homeostatic processes. Nevertheless, 
there are plenty of data suggesting that cholesterol and/or its derivative acts as a mediator of the 
effects of dyslipidemia and/or obesity in breast cancer pathogenesis (31). 
Another important aspect of studies on altered lipid metabolism is the analysis of fatty acid 
composition, which is a simple and direct reflection of the main alterations in the lipid synthesis 
and metabolism. It has been shown that fatty acid composition in normal adipose tissue is a good 
indicator of long-term intake of different fatty acids as normal cells rely heavily on circulating 
dietary lipids (32). However, in cancer cells, 90% of triglycerides were synthesized de novo. As a 
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result, fatty acid composition in cancer cells is controlled and regulated by their special metabolic 
requirements rather than just the dietary input. Therefore, the study of fatty acid compositional 
changes in cancer subjects is far more than a study of dietary fatty acid input as in the case of 
normal subjects, but rather a study of the influence from cancer cells on lipid metabolism. For 
instance, a three- to four-fold increase in the content of phospholipids has been reported in the 
breast cancer tissue compared with the surrounding normal breast adipose tissue of the same 
women (33). This significant increase in the production of phospholipids is independent from 
dietary input difference and very likely to be a result from high demands of biological membrane 
formation by rapidly proliferating cancer cells.  
Much recent work on lipid metabolism and breast cancer has been focused on the 
understanding of the complex relationship between obesity and cancer. As a common form of 
metabolic dysfunction, obesity is positively associated with higher risk for developing breast 
cancer, poorer prognoses, and diminished responses to chemotherapy. The most recent data show 
that obesity has overtaken smoking as the number one preventable cause of cancer-related deaths 
in the United States. This increased cancer risk could be induced by the systemic metabolic 
dysregulations that accompany obesity, including elevated levels of cholesterol and other lipids, 
and high levels of circulating insulin and hormones. However, it has remained largely elusive 
regarding which host factors are the key factors mediating the obesity-cancer link, which is a major 
challenge in understanding the complex mechanisms linking obesity and cancer.  
1.3   Polyunsaturated fatty acids in breast cancer 
Fatty acids can be classified as saturated fatty acids, monounsaturated fatty acids, and 
polyunsaturated fatty acids (PUFAs) based on the number of unsaturated bonds in the fatty acid 
chain, as shown in Figure 1.1. The unsaturated bonds in the long chain improve the flexibility and 
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permeability of biological membranes, allowing the transportation of nutrients and waste products. 
Although PUFAs only account for approximately 12% of the fatty acid content in normal and 
cancerous human adipose tissue (34), PUFAs have recently gained more attention due to their 
important role in modulating membrane properties, receptor signaling, and the expression of 
several key genes in adipogenesis (35).    
 PUFAs can be categorized into two groups: n-3 fatty acids and n-6 fatty acids, depending 
on the location of the first double bond relative to the omega end of the fatty acid chain, as shown 
in Figure 1.1. For instance, for an n-3 fatty acid, the first double bond occurs between the third and 
fourth carbon atom away from the omega end.  Because linoleic (n-6) and α-­‐‑linoleic (n-3) acids 
cannot be synthesized de novo by mammals, both types of fatty acids are defined as essential fatty 
acids and have to be obtained through diet. The n-3 fatty acids can be obtained from high-fat fish 
such as salmon and tuna, whereas n-6 fatty acids are mainly obtained through organ meats and 
vegetable oils, such as soybean and corn oil (36). Both of these are stored in esterified form in 
phospholipids of biological membranes for cells and organelles, or in phospholipids and glycerides 
found in lipid droplets (37,38). Once released from an esterified form, these fatty acids are further 
metabolized to eicosanoids and other autacoids. Because the same series of enzymes are used for 
the metabolism of n-3 and n-6 fatty acids, an excess of one fatty acid will cause a significant 
decrease in the metabolism of the other due to the competition of the same enzymes (35).  
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Figure 1.1 Chemical structure of saturated, monounsaturated, and n-3 and n-6 polyunsaturated fatty 
acids (39).  
Although the mechanisms of PUFAs affecting biological systems are not completely 
understood, it is well acknowledged that PUFAs plays several key roles in cellular functions. First 
of all, PUFA content of biological membranes significantly alters membrane fluidity and 
permeability, thereby influencing vesicle budding and fusion, and protein function and 
trafficking (35). With an increase in the PUFA levels, membrane fluidity increases greatly as 
conformational states can be rapidly changed with substantially more flexible PUFA acyl chains. 
Membrane fluidity also increases with the n-6 fatty acid composition since n-6 arachidonic 
(AA; 20:4) acyl chains have been shown to be more deformable and form softer bilayer than n-3 
docosahexaenoic (DHA; 22:6) acyl chains (40). Secondly, PUFA-derived messengers showed 
anti-inflammatory (n-3) or pro-inflammatory (n-6) effects. The n-6 derivatives promote 
inflammation by increasing vascular permeability and producing inflammatory cytokine whereas 
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the n-3 derivatives reduce inflammation by suppressing the synthesis of inflammatory cytokines 
and chemokines, and elevating the production of anti-inflammatory autacoids (41,42). Finally, 
PUFAs affect cellular metabolism, growth, and differentiation through modulating gene expression, 
especially genes involved in lipid metabolism. Genes related to more active fatty acid transport 
and metabolism tend to be upregulated by PUFAs, such as acyl CoA synthetase (43) and fatty acid 
transport protein (44), whereas lipogenic genes such as fatty acid synthase (45) and stearoyl CoA 
desaturase 1 (46) tend to be suppressed by PUFAs. However, no certain conclusion has been drawn 
on the functions of PUFAs because fatty acid metabolism is found to be site-specific and such gene 
regulations vary among different adipose tissues.   
Given the important roles of PUFAs in cellular metabolism, growth, and differentiation, 
extensive studies have been trying to clarify the cause and effect relationships between PUFAs and 
cancer progression. However, these studies have produced equivocal results, with many finding 
no correlation, some implicating a protective effect, and others indicating PUFAs as a significant 
risk factor. Some of these discrepancies can be attributed to the differences between n-3 and n-6 
fatty acids or the difference of the impact of PUFAs on different types of cancer. Indeed, n-6 
PUFAs have been shown to promote tumorigenesis via increasing circulating estrogenic 
compound levels (47), cell proliferation rate (48), and inflammation (49), while n-3 PUFAs have 
been shown to be responsible for suppressing tumor growth by decreasing circulating estrogenic 
compound levels (47), breast cancer cell growth (50), and HER2 expression (51). One recent 
cohort study demonstrated that patients with breast cancer had significantly lower n-3 fatty acids 
but seemingly higher average n-6 fatty acids. It was also demonstrated, in a cancer cell study, that 
PUFA content is positively associated with higher metastatic ability in breast cancer cells (52). 
These observations strongly suggest a link between PUFA levels and breast cancer development.  
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1.4   Summary 
Altered lipid metabolism is a hallmark of breast cancer (26,27,30). An increase in PUFA 
levels has been positively associated with the aggressiveness of cancer cell lines (52) and the 
promotion of tumorigenesis (53). It has been shown that higher PUFA levels increase the risk of 
metastasis in cancer patients by increasing estrogen levels (47,53), by the expression of cancer-
promoting genes such as PAI-1 (54,55), and by the adherence of circulating tumor cells to blood 
vessel walls and remote organs (56). Although it is known that lipid metabolism is drastically 
altered in cancer cells, it is not known whether such effects occur in more distant tissue sites, i. e. 
the macroenvironment. Evidence from other lipid-related studies strongly suggests that metabolic 
diseases such as obesity and diabetes can interfere with several lipogenic regulatory pathways, 
which in turn may give rise to an increased predisposition for cancer (57,58). Despite the 
importance of these studies to the development of new interventions and therapeutics, further 
investigations are hindered by the lack of reliable biochemical signatures for the tumor 
macroenvironment. Hence, the goal of this thesis is to discover biochemical signatures that reveal 
unusual activity in lipid metabolism in the tumor micro- and macroenvironment in breast cancer.  
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2   Raman spectroscopy  
2.1   Raman spectroscopy: theory  
Raman spectroscopy is a noninvasive, label-free, and chemical-specific technique that 
probes molecular structure based on the scattering interaction between incident photons and 
targeted matter. When light is scattered from a molecule, a large proportion of the photons are 
elastically scattered and end up with the same energy (i.e. frequency) as the incident photons, 
whereas a very small fraction of the photons (approximately 1 out of ten million photons) are 
scattered at a lower or higher frequency, which is called inelastic scattering (59,60). Raman 
scattering is an inelastic scattering process in which the incident photon interacts with the 
electronic cloud of the molecule and results in an energy transfer from or to various molecular 
vibrational modes, accompanied by a frequency shift of the incident photon (61).  
If a molecule is in the vibrational ground state before the irradiation of incident photons, its 
final state will be either the same vibrational ground state, called Rayleigh scattering or elastic 
scattering, or an excited state, called Stokes Raman scattering. In Stokes Raman scattering, abiding 
by the law of energy conservation, a molecule absorbs an incident photon of frequency iv  and 
emits a Raman photon of lower frequency at Rv  simultaneously, accompanied by its transition 
from the ground state to an excited state.  In this case, the energy difference between the vibrational 
ground state and the final excited state is calculated by: 
 ( )i RE h v vΔ = −   (2.1) 
where h is Planck’s constant (units J s⋅ ). The vibrational energy gained by the molecule is 
ultimately dissipated as heat. On the other hand, if the molecule begins in an excited vibrational 
mode, it will transfer energy to the photon and return to the vibrational ground state, called anti-
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Stokes Raman scattering. In anti-Stokes Raman scattering, the incident photon of frequency iv  
gains energy from the molecule and results in a scattered photon with higher frequency Rv . The 
energy difference in this case is calculated by: 
 ( )R iE h v vΔ = − . (2.2) 
As shown by Eqn. (2.1) and Eqn. (2.2), anti-Stokes and Stokes Raman scattering carry identical 
frequency information about the molecule. According to a Boltzmann distribution, the ratio of the 
populations of the excited state to that of the ground state should be very low at room temperature. 
Therefore, Stokes Raman scattering is usually the dominant transition measured in Raman 
spectroscopy. 
According to Eqn. (2.1) and Eqn. (2.2), the vibrational modes of a certain molecular structure 
can be assessed by calculating the difference between the frequency of the incident photon and the 
Raman-scattered photon. Thus, by recording the frequency shifts of the incident photon, the 
structure of the probed molecule can be revealed. In Raman spectroscopy, this idea is implemented 
by using a monochromatic laser as an excitation source and measuring the spectrum of the 
scattered light. In order to understand the physical meaning of Raman spectral bands, the classical 
electromagnetic field description of Raman spectroscopy can be used: 
 P= Eα  (2.3) 
where P is the dipole moment induced in the molecule, α  is the polarizability of the molecule, 
and E is the applied electric field. When the polarizability of a molecule stays unchanged, the 
induced dipole emits light at the same frequency as the incident photon. Considering the 
fluctuation with time of the incident electromagnetic wave, the induced electric dipole moment 
can be expressed as: 
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0P= cos2 iE v tα π  (2.4) 
where 0E  is the intensity and iv  is the frequency of the applied electric field. However, in Raman 
scattering, the polarizability of a molecule is changed by its molecular vibrations. Using small 
perturbation theory, the polarizability can be approximated as: 
 
0 0( ) k
k
Q
Q
αα α ∂= +
∂
 (2.5) 
in which 0α  is the original polarizability, and kQ  describes the normal mode of vibration in the 
molecule at frequency kv  with amplitude 
0
kQ : 
 0 cos 2k k kQ Q v tπ= .  (2.6) 
When inserting Eqn. (2.5) and Eqn. (2.6) into Eqn. (2.4), it can be seen that the polarizability takes 
on the form:  
 0
0 0 0 0P= cos2 ( ) cos2 cos2i k i k
k
E v t E Q v t v t
Q
αα π π π∂+
∂
. (2.7) 
Applying common trigonometric relations, Eqn. (2.7) can be written as: 
 0
0 0 0 0 )
1P= cos2 ( ) [cos2 ( ) cos2 ( ]
2i k i k i kk
E v t E Q v v t v v t
Q
αα π π π∂+ + + −
∂
. (2.8) 
The first term is Rayleigh scattering, the second term is the anti-Stokes Raman scattering, and the 
last term is Stokes Raman scattering. It can be readily seen from Eqn. (2.8) that in order to be 
Raman-active, the polarizability of the electron cloud must be changed. Thus, the Raman selection 
rule is given by: 
 
0
kQ
α∂ ≠
∂
. (2.9) 
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Even when the Raman selection rule is satisfied, the Raman signals are still very weak since the 
Raman signal arises from only an extremely small fraction of the incident photons. The Raman 
scattered intensity is given by: 
 4 2
0 ( )iI v I Nf α≅  (2.10) 
in which 0I   is the intensity of the incident light,  N is the number of scattering molecules, and α  
is the polarizability of the sample. The term 2( )f α  is a function describing the square of the 
polarizability derivative, i. e. the square of the induced dipole moment, which is proportional to 
the scattering intensity (62). Eqn. (2.10) is consistent with the Raman selection rule that the Raman 
band will be close to zero if a vibration does not cause an observable change in the polarizability.  
This equation also points out that the intensity of Raman scattering depends on the fourth power 
of the frequency of the incident light. Thus, the choice of the frequency of the excitation source 
largely determines the signal-to-noise (SNR) of the system. 
2.2   Raman spectroscopy: instrumentation 
2.2.1   Considerations of Raman-independent signals 
It is important to note that the Raman signal is accompanied by strong Raman-independent 
background signals, including Rayleigh scattering, absorption, and fluorescence, as shown in the 
Figure 2.1. A typical cross-section for absorption, fluorescence, Rayleigh scattering, and Raman 
scattering is approximately 10-16, 10-18, 10-28, and 10-30 cm2, respectively. Rayleigh scattering and 
Raman scattering can vary significantly in different circumstances because both of them depend 
strongly upon the excitation frequency and the effect of the absorption band. Given the 
significantly smaller Raman scattering cross-section, these Raman-independent signals have to be 
taken into consideration in order to retrieve the extremely weak Raman signals.  
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Figure 2.1 Jablonski diagrams depicting the main optical processes that occur in Raman spectroscopy. 
 
These three Raman-independent processes have different effects on the detection of Raman 
signals in Raman spectroscopy and are eliminated or minimized via different approaches. 
Absorption weakens the signal considerably but a high-power laser and a high-sensitivity camera 
can largely solve this problem. Rayleigh scattering and anti-Stokes Raman scattering can be 
rejected from detection simply by using high-quality notch filters. Among these confounding 
factors, the most challenging one is the fluorescence since it generates red-shifted signals, which 
readily overlap with the spectrum of Stokes Raman scattering. One way to reduce the fluorescence 
in Raman spectroscopy is to switch to an excitation source at a longer wavelength, which leads, 
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however, to a lower Raman scattering cross-section. Reduction of fluorescence can also be 
accomplished by employing background removal algorithms since Raman bands are much 
narrower and shaper than fluorescent bands (63).   
2.2.2   Raman micro- and macro-spectroscopy 
A schematic of a typical laboratory Raman system is shown in Figure 2.2. A monochromatic 
laser with high average power is required and directed into either an optical microscope (micro-
spectroscopy, or confocal Raman microscopy) or focused onto a macroscopic sample (macro-
spectroscopy, or regular Raman spectroscopy). Backscattered light is collected by the objective 
and then sent to a spectrometer following appropriate filtering. The excitation source can be at 
various visible and near-infrared wavelengths. Longer-wavelength excitations are usually 
preferred when examining biological samples since they produce less fluorescent background.  
 
Figure 2.2 Schematic of Raman spectroscopy. 
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The main difference between Raman macro-spectroscopy and micro-spectroscopy is that the 
latter has a much smaller probed volume and therefore a higher spatial resolution. This approach 
avoids the volume averaging effect, but at the sacrifice of SNR, working distance, and field-of-
view. Whether the researcher should choose Raman macro-spectroscopy or micro-spectroscopy 
depends highly on the application. For clinical investigations, in which examination speed and 
area are a priority, Raman macro-spectroscopy is preferred as it has much more Raman-active 
molecules within the probed volume, thereby resulting in better SNR and larger field-of-view. A 
good example is that, via an optical fiber probe, Raman spectroscopy can provide real-time, even 
intraoperative, detection of brain cancer (64). Nevertheless, identifying and understanding the 
biochemical basis underlying these potential applications is an important and necessary step 
toward developing more powerful and reliable diagnostic tools. Furthermore, when the 
biochemical changes are subtle and only occur at the microscopic level, they can rarely be detected 
by Raman macro-spectroscopy. In these circumstances, Raman micro-spectroscopy is commonly 
used, for its higher spatial resolution and chemical specificity.  
2.3   Raman spectroscopy: application  
Raman spectroscopy provides quantitative, label-free, and molecule-specific analysis of all 
major chemical constituents of the sample. Despite the rich information contained in the Raman 
spectrum, the development of Raman spectroscopy for further applications has been largely 
inhibited due to the extremely weak Raman signals. However, during the past few decades, there 
has been rapid developments in instrumentation, including new lasers, filters, spectrometers, and 
cameras. Raman spectroscopy has been extensively utilized in biomedical and clinical 
investigations, for instance, for delineating cell and tissue types based upon compositional changes 
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in minerals and proteins (65), tracking changes in the abundance of mRNA and proteins throughout 
stem cell differentiation (66), and discriminating types and grades of neoplasms (67). 
Cancer continues to persist as one of the leading causes of death throughout the world. Early 
detection and improved diagnosis are the key to efficacious cancer treatments. Since Raman 
spectroscopy has the capability to provide detailed chemical information, including the 
biochemical changes accompanying carcinogenesis, it has been widely used for the diagnosis of a 
wide variety of cancers. For instance, much interest has been devoted to the detection of skin 
cancer, the disease that one in five Americans will develop in the course of a lifetime (68). A real-
time Raman spectroscopy has been demonstrated for the in vivo diagnosis of skin cancer with 
sensitivities between 95% and 99% and specificities ranging between 15% and 54% (69). Another 
important application is the detection of invasive brain cancer cells, which cannot be achieved 
using current clinical technologies. For this purpose, a recent study reported a handheld Raman 
spectroscopy probe that can be used for the intraoperative detection of cancer cells in the human 
brain with a sensitivity of 93% and a specificity of 91% (64).  
A large number of studies have investigated the utilization of Raman spectroscopy for the 
diagnosis of breast cancer. For instance, in 2005, Raman spectroscopy was demonstrated to be 
able to distinguish malignant tissues from normal and benign tissues with 94% sensitivity and 96% 
specificity (70). The spectral differences mainly come from the significant increase of collagen 
content and the decrease of fat content in the cancerous tissues. Two years later, it was reported 
that low, intermediate, and high nuclear-grade DCIS (ductal carcinoma in situ) and Grade I-III 
IDC (invasive ductal carcinoma) can be differentiated based on a series of Raman bands defined 
collectively from previous studies (71). This study showed that Raman spectroscopy has a strong 
potential role for guiding decisions and for the staging of breast cancer.  
18 
 
As mentioned above, the power of Raman spectroscopy has been demonstrated in the 
diagnosis of various cancer types by analyzing the abundance of chemical components within the 
tumor (64,70,72). However, its ability to characterize chemical changes outside the tumor, such as 
in the tumor micro- and macroenvironment, has been underappreciated. As Raman signals from 
one single point arise from all chemical components present within the probed volume, a 
considerable part of the rich information carried within the signal can be easily compromised by 
the complex mixtures of chemicals, as well as by the noise and background from the instrument 
and sample. Thus, it is proposed that if these effects are minimized, there is a chance that one could 
identify previously unseen changes in the tumor micro- and macroenvironment.  
The objective of this study, therefore, is to characterize the alteration of PUFA abundance 
in the tumor micro- and macroenvironment in human breast and rat mammary cancer by utilizing 
the power of Raman micro-spectroscopy. Raman micro-spectroscopy was chosen for this study to 
avoid the volume averaging effect and to ensure optimal spatial resolution and chemical specificity 
(73).  
2.4   Statement of work  
This thesis presents Raman micro-spectroscopic analysis of fatty acids in the tumor and the 
tumor micro- and macroenvironments in human breast and rat mammary cancer.  In Chapter 3, 
techniques and algorithms employed in the data acquisition and processing are introduced. Close 
attention is paid to the acquirement and extraction of high-SNR, fatty-acid dominant spectra that 
allow for the detection of the subtle but reproducible biochemical changes in the tumor micro- and 
macroenvironments. Chapter 4 presents the application of this spectroscopic analysis for 
characterizing tumor and the tumor micro- and macroenvironments in rat mammary cancer. In 
Chapter 5, the spectroscopic analysis is applied to characterizing malignant and normal-appearing 
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tissue in human breast cancer. The increased PUFA levels identified at the tumor sites, and within 
the tumor micro- and macroenvironments in both rat models and human subjects demonstrate the 
power of this spectroscopic analysis, and may provide new insights into the mechanisms of how 
breast cancer regulates its environment. A summary of the presented work and suggestions for 
future work are discussed in Chapter 6. 
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3   Data Acquisition and Processing  
3.1   Data acquisition 
3.1.1   Experimental setup 
The experimental setup of the confocal Raman microscope is shown in Figure 3.1. A 
continuous-wave diode-pumped solid-state laser (Ventus, Laser Quantum) operating at a 532 nm 
center wavelength is used as an excitation source in a commercial confocal Raman microscope 
system (Horiba LabRAM HR 3D, Horiba). The beam is directed into a 0.25 N.A. 10× objective, 
resulting in a laser spot size of 2.6 µm at the focus. The beam out of the objective is focused 
directly onto the tissue with a power of ~ 20 mW. Back-scattered light is collected by the same 
objective and sent to a spectrometer. The collected spectral range is 500 to 3500 cm-1 at a spectral 
resolution of 3 cm-1. Wavenumbers are calibrated with spectroscopic features from pure oleic acid 
by linear fitting. A bright-field microscope is used to focus and choose regions of interest.  In this 
particular study, areas that appear to be dominated by lipid droplets, as shown in the bright-field 
image Figure 3.2 are more likely to be selected for the analysis of fatty acids. 
Because SNR is crucial for identifying the subtle alterations in the tumor micro- and 
macroenvironment, 532 nm was chosen as the excitation wavelength, as the Raman intensity is 
inversely proportional to the fourth power of the laser wavelength (Eqn. (2.10)). The main 
disadvantage associated with using shorter wavelengths is the presence of strong autofluorescence 
in the Raman spectra. Nevertheless, it was found that the autofluorescence from the sample can 
largely be quenched by 500-ms illumination with focused excitation light at each point prior to 
data acquisition. In addition to the choice of laser, a 10x objective was chosen over other objectives 
with larger magnification number because it has a relatively longer working distance and is more 
likely to have an acceptable SNR throughout the scanning process of the sample. 
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Figure 3.1 Experimental schematic of the confocal Raman microscope. 
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Figure 3.2 Bright-field image of a tissue area dominated by lipid droplets in fresh human breast tissue. 
 
3.1.2   Parameters for data acquisition 
The parameters for data acquisition were chosen with the intention to minimize the noise 
and volume averaging effect in this study. Raman spectroscopy measurements were performed in 
a two-dimensional grid with a step size of 100 µm and a grid size that ranged from 10 10 to 20
20. Scanning was performed using a motorized stage. The acquisition time for each point was 6 
s. Although 0.5-1.0 s was sufficient to obtain a discernable spectrum, a longer acquisition time was 
preferred to reduce noise. Throughout the imaging session, the tissue sample was kept hydrated 
with drops of a saline solution. The selected areas varied from 1 mm2 (100 spectra) to 4 mm2 (900 
spectra), depending on the size and the shape of the tissue sample. These acquisition times were 
consistent with state-of-the-art commercial confocal Raman spectroscopy systems (52) . 
3.2   Data Preprocessing 
3.2.1   Wavenumber calibration 
×
×
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Even on the same instrument, day-to-day drift in the laser wavelength or the alignment of 
the spectrograph may result in offset errors ranging from 0 to 30 wavenumbers. Hence, 
wavenumber calibration was required every day to ensure the reproducibility of the interpretation 
of the spectra. The wavenumbers were calibrated with spectroscopic features from pure oleic acid 
(Sigma-Aldrich) by linear fitting, as shown in Figure 3.3. 
 
  
Figure 3.3 Raman spectrum of pure oleic acid. 
3.2.2   SNR filtering 
Although the SNR was the priority during data acquisition, there was still a chance that some 
data points would have low-quality spectra due to an uneven tissue surface or sample 
contamination. The inclusion of these highly noisy data could easily obfuscate the subtle spectral 
differences between the fatty acid subtypes. As a result, the filtering of high-SNR spectra was 
performed prior to any further data analysis.  
It was found that spectra of low SNR were usually accompanied by these features: large 
fluctuations, saturation, and especially strong signals in the silent region (1800-2700 cm-1). Thus, 
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spectra with low SNR could be effectively removed by identifying these features. Specifically, if 
any band in the silent region of a spectrum was greater than 1/5th of the highest peak throughout 
the entire Raman spectrum (500-3500 cm-1), then this spectrum was removed. Similarly, if any 
peak was identical to its neighbors, the corresponding spectrum was classified as being a saturated 
signal and removed from the data pool.   
3.2.3   Fluorescence removal 
It was expected that the Raman spectra of biological samples would often accompanied by 
observable fluorescence at the excitation wavelength of 532 nm, even after fluorescence quenching. 
Fortunately, the spectra from fluorescence have much more slowing varying peaks than Raman 
spectra. Based on this signature, they could be removed by a variety of methods, including band 
pass filtering in the Fourier domain, point difference derivatives, Savitsky-Golay derivatives, and 
baseline fitting. In this study, fluorescence was removed by baseline fitting and correction 
(msbackadj; MATLAB; Mathworks, Natick, Mass.). Figure 3.4 shows the spectrum before and 
after baseline correction. 
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Figure 3.4 Fluorescence removal.  Curve in blue is the Raman spectrum before baseline correction. Curve 
in red is the Raman spectrum after baseline correction. 
 
3.2.4   Normalization 
According to Beer’s law, spontaneous Raman scattering has a linear dependence on the 
analyte concentration (74). However, the day-to-day fluctuations of the instrument made it 
impossible to apply Beer’s law to the absolute Raman intensity. Therefore, normalization or 
ratiometrics was a requirement for reliable quantification of Raman signals. In the present study,  
Raman spectra were normalized against the peak at 1440 cm-1 (CH2 bending mode of proteins and 
lipids (75)). 
26 
 
3.3   Extraction of unsaturated fatty acids 
3.3.1   Pattern recognition algorithm  
A pattern recognition algorithm was employed to match the acquired Raman spectra against 
a pre-defined library of fatty acid (FA) spectra so that interference from other chemical species 
would be minimized. 
The extraction of fatty acids can be accomplished by either decomposition methods or 
classification methods. These two methods hold different assumptions of the dataset and inevitably 
introduce different types of artifacts into the final results. For instance, multiple linear regression 
(MLR), a commonly used decomposition method, works well for the decomposition of a spectrum 
with a limited number of distinct basis elements. However, given the fact that there are at least 
nine basis spectra present in breast tissue and the orthogonality between these basis spectra is not 
ideal (70,76), the risk of overfitting by decomposition will be high. The artifacts resulting from 
this overfitting problem will vary from sample to sample and can strongly inhibit the identification 
of the subtle spectral differences between normal and normal appearing tissue. Therefore, 
decomposition is not suitable for this application and classification methods were explored. 
Normally this option would result in an undesired rejection of a large proportion of the data which 
are not classified as fatty acids. However, in this particular study, the rejection rate is not an issue. 
The first reason is that fatty acids are abundant in breast tissues (except in solid tumors). Second, 
during data acquisition, areas dominated with lipid droplets (Figure 3.2) were purposely preferred, 
thereby increasing the number of fatty-acid dominated samples. Finally, fatty acids have an 
extremely strong Raman scattering cross-section compared to the other main chemical components 
of breast tissue (76). Therefore, classification is a reasonable approach for this particular study.  
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Principle component analysis (PCA) has been shown to be very effective in spectroscopic 
analysis where the classification of benign and malignant tissue is needed (77). However, it needs 
to be noted that the computed principal components from PCA are not necessarily correlated to 
the studied property. In this particular study, the correlation between the studied property and the 
classification results needs to be strong since the ultimate goal of this study is not only to 
differentiate normal appearing breast tissue from healthy tissue, but more importantly, to discover 
the specific biochemical changes in the tumor micro- and macroenvironment in breast cancer. 
Under this circumstance, it is important to build a classifier based on the chemical constituents of 
the tissue sample. 
The design of a classifier depends highly on the availability of labeled samples. If the 
respective sample sizes of each class are large and can be assumed to be representative of the actual 
probability distribution, Bayes-decision based methods, such as linear discriminant analysis 
(LDA), quadratic discriminant analysis (QDA), and Naïve Bayes classifier, can be used as they 
optimize the expected misclassification rate and produce optimal results (78). However, in this 
study, the size of the training data is limited. Thus, our classifier has to rely on the distance or 
similarity in feature space, which leaves k nearest neighbor (kNN), support vector machine (SVM), 
logistic regression, and decision trees. Furthermore, one must consider the nature of the Raman 
spectral content, which is a mixture of all chemical constituents present in the probed volume. The 
Euclidean distance metric used in kNN provides a straightforward way to filter out those spectra 
that are not dominated by fatty acids. Therefore, kNN was the best choice for this study and 
scenario. A more detailed description of the kNN approach will be given in Section 3.3.3. 
3.3.2   Library design  
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As the extraction of fatty acids relies on matching tissue spectra to a pre-defined library of 
fatty acids, the construction of this pre-defined library of pure chemical compounds is an important 
and necessary step. The library was composed of reference spectra obtained from pure chemical 
compounds that are the main components of rat mammary and human breast tissue. These main 
components include unsaturated fatty acids (oleic acid and linoleic acid), the cell nucleus (DNA), 
cell cytoplasm (actin), collagen (collagen type I, III, IV and V), and cholesterol (76). These 
compounds were purchased from Sigma-Aldrich and were used without modifications. The basic 
spectra for the construction of the library are shown in Figure 3.5. Saturated fatty acids were 
excluded in the analysis because it was found that saturated fatty acids account for very few of the 
spectroscopic features observed. In addition, Raman spectra from saturated fatty acids and spectra 
from unsaturated fatty acids were not sufficiently similar to be represented by one group.  
 
  
Figure 3.5 Raman spectra library of the six pure chemicals that are the main contributors to Raman signals 
from mammary tissue. (A) Fingerprint regime. (B) CH regime. All the spectra were preprocessed and 
normalized to the intensity at 1440 cm-1. 
3.3.3   kNN classification 
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The kNN classification is a simple yet effective non-parametric classification method. It 
consists of three main steps. (1) Searching k training samples that are nearest to the input x. The 
set of these k training samples are denoted as ( )kN x . (2) Counting the number of samples in each 
class in ( )kN x . (3) Estimating the probability of x belonging to class c by the following empirical 
fraction:  
 ( )
( )
( )1| ,  II
k
i
i N x
p y c x K y c
K ∈
= = =∑ . (3.1) 
Intuitively, every input sample finds the k most similar samples in the training data, then 
these k training samples vote for the class of the input data based on their own classes. The 
similarity between samples is usually measured by Euclidean distance. An example for the 
Euclidean metric in two-dimensional feature space is given by: 
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(3.2) 
Thus, the k most similar samples are also the k nearest neighbors of the input data. 
Although the idea behind this method is quiet simple, in theory when there exists enough 
training samples, the kNN classifier can reach within a factor of 2 of the best possible 
performance (79). Additionally, in practice, as demonstrated previously in the MNIST database of 
handwritten digits, the kNN classifier can achieve performance comparable to the convolutional 
neural network with proper settings (test error rate: 1.1% vs 0.7%) (80). 
It should be noted that the performance of kNN methods could easily suffer from the curse 
of dimensionality. In the case of spectrum classification, if one were to use the raw spectrum as 
the input vector, the input vector will have more than 1000 elements, and so will the dimension of 
the feature space in the kNN methods. The Euclidean distance of two-dimensional space is shown 
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in Eqn. (3.2). When it is expanded to a d-dimensional space, the Euclidean ball of radius r centered 
at x is described by: 
    ( , ) { ' :|| ' || }dB x r x R x x r= ∈ − ≤ . (3.3) 
Its volume is denoted by:  
 2 /2( )[ ( , )]
( / 2 1)
drVol B x r
d
π=
Γ +
 
(3.4) 
in which Γ  is the Gamma function. For 2d k= , this results in: 
  ( / 2 1) !d kΓ + = . (3.5) 
Applying Sterling’s approximation, this becomes: 
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when k  approaches positive infinity. Inserting Eqn. (3.5) and Eqn. (3.6) into Eqn. (3.4) gives: 
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(3.7) 
Hence, as the dimension 2d k=  approaches positive infinity, the volume of a sphere with finite 
radius always tends to be zero. This phenomenon makes it very difficult to determine the closest 
neighbors in high-dimensional space. Therefore, instead of using the raw spectra, a subset of the 
spectral features was used for classification in order to reduce the dimension of the feature space.  
 A total of 14 spectral features were selected based on their uniqueness to each chemical 
component and their impact on the final classification: 787, 816, 855, 936, 1001, 1031, 1127, 1243, 
1303, 1312, 1342, 1581, 1655, and 1745 cm-1. The assignments for these Raman bands can be 
found in Table 3.1. After feature selection, the intensity 
iw
I  at the wavelength wi was used as one 
of the features of the spectrum. More specifically, each spectrum was represented by a feature 
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vector 
1 2
[ , , , ]
nw w w
I I I… . The kNN classification was then applied to assign a class label to the input 
spectrum based on the basis spectra represented by the k closest neighbors of the feature space. 
Furthermore, two modifications were made to the kNN classifier to make it more suitable for this 
particular study. (1) After the classification decision was made, to ensure the dominance of fatty 
acids in every spectrum, every input data x that has a distance larger than a preset distance l to the 
nearest training sample in the corresponding class was classified as “mixture”.  (2) An iterative 
scheme was used to generate training data based on the pure chemical samples. 
Matching results for fatty acids in the rat mammary tissue samples are shown in Figure 3.6. 
The high degree of similarity between the reference fatty acid spectra and the observed tissue 
spectra, along with the narrow standard deviation of the extracted tissue spectra, demonstrates the 
efficiency of the matching algorithm.  
One modification was made to the matching algorithm for human studies due to the presence 
of strong resonant signals from β-carotene found in human breast tissue but not in the rat mammary 
tissue. Since β-carotene is strong in the fingerprint vibration region but almost silent in the CH 
vibration region, and fatty acids have unique spectroscopic features in the CH region compared 
with other major basic components, fatty acids acquired from human breast tissue were classified 
based on the CH vibration region. 
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Figure 3.6 Unsaturated fatty acids were extracted with high accuracy by using a matching algorithm. The 
library of unsaturated fatty acids includes multiple spectra from pure oleic acid and linoleic acid, which most 
of the unsaturated fatty acids resemble in their Raman spectra. The standard deviation is represented by the 
shaded area. The small standard deviation demonstrates the high precision of our classification methods for 
unsaturated fatty acids. 
3.3.4   Decomposition of spectrum by ordinary least square regression 
Previous studies showed that β-carotene is extremely lipophilic and often found in 
conjunction with fat throughout the human breast (76). To avoid possible signal interference 
between β-carotene and fatty acids, multiple linear regression was employed prior to peak analysis 
to retrieve the relative concentration of fatty acids and β-carotene within a single spectrum. 
Multiple linear regression is an extension of the simple linear regression model; it attempts to 
retrieve the relationship between multiple predictor variables and one response variable by fitting 
a linear model to the observed data. The general multiple linear regression model takes on the form: 
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(3.8) 
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where iy  is the real response for the i th observation, ijx  is the j th predictor of the i th 
observation, 0β  is the regression intercept, and jβ  is the regression slope for the j th predictor, 
which is the relative concentration of the j th chemical component in this application. In order to 
simplify the optimization problem, Eqn. (3.8) can be written in matrix notation as: 
 y = Xβ+ ε . (3.9) 
To estimate the best model parameters, ordinary least squares (OLS) was used to minimize the 
sum of the squared loss function eSS . This OLS problem can be written as: 
 min( ) mineSS =
2
β
|| y - Xβ ||  . (3.10) 
Taking the first derivative of the squared loss function with respect to β  gives the OLS solution: 
 ˆ T -1 Tβ = (X X) X y . (3.11) 
Thus, with an accurate model given by βˆ , decomposition of spectra into fatty acid and β-carotene 
can be performed, allowing the fatty acid content to be extracted from the total Raman intensity. 
Model fits to a sample Raman spectrum are shown in Figure 3.7. The flatness of the residual 
spectra demonstrates that accuracy of the designed model. 
In this particular model, the basis spectra for the model were acquired from pure β-carotene, 
oleic acid, and linoleic acid. Because oleic acid and linoleic acid have a very high degree of 
similarity, they were not sufficiently orthogonal to be easily differentiated in the multiple linear 
regression. In addition, to avoid overfitting, it was important to involve as few elements as possible 
while retaining important spectroscopic features. Hence, it was reasonable to use one basis element 
to represent both monounsaturated fatty acids and PUFAs in the model by extracting their common 
spectroscopic feature. Therefore, instead of using three full Raman spectra, two sets of several 
Raman peaks were used to implement model fitting: 1005 cm-1 (carotenoids), 1154 cm-1 (β-
34 
 
carotene), 1515 cm-1 (β-carotene), 1440 cm-1 (unsaturated fatty acids), 2303 cm-1 (β-carotene), 
2661 cm-1 (β-carotene), 2897 cm-1 (unsaturated fatty acids). More detailed assignment information 
for these Raman bands can be found in Table 3.1. 
 
 
Figure 3.7 Removal of β-carotene from spectra by model fitting. (A) Raman spectra of three pure chemical 
components involved in the model. (B) Results of model fitting. Common peak signatures of the two fatty 
acids were used as one element and the unique peak signatures of carotenoid were used as the other basic 
element. Model fitting of the entire spectrum is not used to avoid overfitting due to similarity between the 
two unsaturated fatty acids. (C) Based on the model fitting coefficients, the fatty acid content is extracted by 
subtracting the portion of β-carotene. 
3.4   Raman peak analysis 
After the matching process, spectra that were dominated by features of fatty acids were 
selected for the peak analysis. In the peak analysis, Gaussian-peak fitting was used to decompose 
overlapping-peak spectrum into its component parts. Peak intensity was then calculated by finding 
the local peak of the fitted Gaussian line. All spectral analyses were performed in MATLAB. 
3.4.1   Peak fitting 
For independent peaks, peak intensity can be easily acquired by finding the local maximum. 
However, when peaks overlap with each other, peak analysis by simply finding local maximum at 
the peak of interest introduces undesired contribution from the neighbor peaks. This describes the 
situation for one of the Raman peaks that this study relied on, the Raman band at 3010 cm-1, which 
lies at the tail of the neighbor peak around 2900 cm-1, as shown in Figure 3.8. Decomposition of 
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the overlapping-peak spectrum into its individual components must be performed prior to further 
statistical analysis.  
There are several considerations that must be made in order to make a peak fitting model 
scientifically reliable and meaningful. Assumptions about the vibrational line shapes have to be 
made. The observed overall line shape is a sum product of all the individual vibrations, which 
depends on the environment of each individual molecule. For instance, in solids, where the 
molecules are locked in space and the excited molecule relaxes before suffering from incoherence, 
the resulting line shape is Gaussian. On the other hand, in gases, where rapid motions occur 
frequently and loss of coherence is the dominant source of energy loss, the line shape takes on a 
Lorentzian profile. In liquids, where the molecules are not fixed in space but not as mobile as those 
in gases, the line shape is a combination Gaussian-Lorentzian profile. In the case of breast tissue, 
a Gaussian profile fits the Raman line shape the best and produces the smallest error among all 
three profiles.  
Furthermore, it is important to have certain prior knowledge about the biochemical meaning 
of individual peaks in order to make the fitting procedure scientifically meaningful. First, fitting 
with a large number of peak components usually produces a nearly perfect residual, but is useless 
for interpretation and prone to be overfitting. Thus, predicting the number of major peak 
components based on the chemical structure and the acquired line profile is needed prior to peak 
fitting. Similarly, an initial guess of the position, width, and height of the individual peaks could 
help improve the accuracy and optimization speed of the peak fitting procedure. Given these 
considerations, peak fitting was performed with the following parameters as shown in Figure 3.8. 
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Figure 3.8 Peak fitting. The blue dots represent the original data points of the Raman spectrum. The two 
green curves are the resulting basis peaks via decomposition. The red curve is the fitted line based on the 
fitting results.  
 
 
3.4.2   Raman band assignment 
Table 3.1 provides the band assignments for the Raman bands that were used in this work.  
37 
 
Table 3.1. Assignments of the major Raman bands.  
Wavenumber  
(cm-1) Assignment 
787 DNA Can be taken as a measure for the relative quantity of nucleic acids present  
816 C-C stretching of collagen 
855 Proline 
936 Proline (collagen type I) 
1001 Phenylalanie (collagen) 
1005  β-carotene 
1031 C-N stretching of proteins 
1127 C-N stretching of proteins 
1154  C-C (&C-N) stretching of β-carotene 
1243 Collagen 
1267 C=C groups in unsaturated fatty acids 
1303 CH2 deformation of lipids 
1312 CH3CH2 twisting mode of collagen 
1342 DNA/RNA 
1440  CH2 bending of fatty acids 
1515  C-C stretch mode of β-carotene 
1581 C=C bending mode of phenylalanine 
1655 C=C stretching of lipids 
1745 C=0 stretching of lipids 
2303  OH-NH-CH stretching regions of β-carotene 
2661  C-H stretch of β-carotene 
2897  CH stretch of lipids and protein 
3010 Unsaturated =CH stretch 
 
3.4.3   Statistics  
To determine whether tissue samples from healthy and cancerous subjects had significantly 
different degrees of fatty acid unsaturation, a Kruskal-Wallis test was used (kruskalwallis; 
MATLAB), followed by a multiple comparison test (multcompare; MATLAB) with =0.05.  
 The Kruskal-Wallis test is a rank-based nonparametric (distribution free) method that can 
be used to test whether the samples of two or more groups are from identical distributions. It is 
sometimes also called the “nonparametric one-way ANOVA” and is usually used when the 
assumptions of one-way ANOVA are not met. In a one-way ANOVA, it is assumed that the 
α
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distribution of each group follows a normal distribution and the variance within the groups is 
approximately equal. However, in this study, as shown by the density distributions in Figure 4.2 
and Figure 5.2, the data from normal appearing tissue do not take the form of a normal distribution 
and have much larger variation than the data from cancerous and healthy tissue. Therefore, the 
Kruskal-Wallis test was used in this study to test whether data from different locations of cancerous 
and healthy rats share the same distribution.  
It should be noted that the Kruskal-Wallis test only provides information on whether there 
is a statistically significant difference between groups; it cannot determine where the difference 
lies between specific groups. To find out which specific groups are statistically different from each 
other, the post hoc test was used. The prerequisite for running a post hoc test is a significant 
Kruskal-Wallis result, which shows an overall significant difference between the groups.    
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4   Quantification of PUFAs in rat mammary cancer 
4.1   Study design 
An ex vivo imaging study was performed to investigate the biochemical changes in the tumor 
micro- and macroenvironment of mammary cancer in a pre-clinical rat model using Raman micro-
spectroscopy. Fresh rat mammary tissues were obtained from a total of 10 female rats and imaged 
immediately after their removal. 
Animal procedures were conducted in accordance with a protocol approved by the 
Institutional Animal Care and Use Committee at the University of Illinois at Urbana-Champaign. 
To induce mammary tumors in the female Wistar-Furth rats (Harlan, IN), N-nitroso-N-methylurea 
(NMU; 12.5 mg/mL; Sigma, St. Louis, MO) was injected intraperitoneally at a concentration of 
55 mg/kg into the left side of the abdomen when the animals were 7 weeks old. One week later, 
the same amount of NMU was injected intraperitoneally into the right side of the abdomen. After 
approximately 12 weeks of age, when the mammary tumors became palpable, primary tumor sites 
and non-tumor mammary tissue at different distances from the primary tumors were removed and 
immediately assessed spectroscopically.  
The data collected from rat mammary tissue were divided into four groups: tumor sites, 
tumor microenvironment, tumor macroenvironment, and control. Tumor sites were harvested from 
the solid palpable primary tumors. The tumor microenvironment refers to surrounding mammary 
tissue within a distance of 1 cm from the center of the primary tumor. The tumor 
macroenvironment represents tissues collected more than 3 cm away from the primary tumor. The 
control group is for healthy mammary tissue from rats with no treatment. More specific 
information about the number of samples can be found in Table 4.1.  
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Table 4.1. Rat mammary tissue samples used in this study. 
Rat Type  Rats 
(n) 
Samples 
(n) 
Experiment  Injected with NMU   
 Tumor sites 5 10 
 Surrounding tissue 1 cm away from center of visible tumor 5 17 
 Mammary tissue more than 3 cm away from the center of visible 
tumor 
5 13 
Control Injected with PBS   
 Healthy mammary tissue  5 37 
Total  10 77 
4.2   Results and discussion 
4.2.1   Spectral signatures of PUFAs 
Figure 4.1 provides the spectral analysis of the fatty acids from the tumor sites, the tumor 
microenvironment, the tumor macroenvironment, and control samples. Consistent with previous 
results, Raman spectra of fatty acids in normal mammary tissue appear to be dominated by Raman 
features of oleic acid, a monounsaturated fatty acid that is the most abundant fatty acid in 
mammalian cells (81). Conversely, a higher average degree of unsaturation (3010 cm-1) was found 
in the tissue of tumor-bearing rats, implying an increase in PUFA levels.  
However, as the peak at 3010 cm-1 is overlapping with the tail of the strong neighboring CH 
band, the higher intensity observed at 3010 cm-1 in cancerous rats could be attributed to the 
stronger base line from the CH region rather than from increased PUFA levels. Decomposition of 
the overlapping peaks and systematic quantification were needed to provide a more objective and 
comprehensive analysis of fatty acid content for each type of tissue samples. 
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Figure 4.1 Average tissue spectra and representative reference spectra. A. comparison of average Raman 
spectra of fatty acids in the mammary tissue from tumor-bearing rats, and healthy mammary tissue from 
control rats. Shaded curves show the corresponding standard deviations of all spectra acquired from each 
group. The major peak used for quantifying the degree of unsaturation is marked with shaded vertical bands 
(3010 cm-1). B. Raman spectra of two pure reference fatty acids (oleic acid and linoleic acid) in the CH region 
from 2800 cm-1 to 3050 cm-1. 
4.2.2   Distribution of PUFAs  
For a better understanding of the trends observed in these spectra, quantification of the entire 
tissue sample was performed to analyze fatty acid composition. By Beer’s law, the ratio of the 
Raman intensity at 3010 cm-1 (  stretching vibration (82)) to the intensity at 1440 -1cm  
(CH2 deformation (83)), , depends linearly on the ratio of the number of  
groups to the number of  groups (84). A ratio value (
2
/C H CHN N= − ) higher than 1/7 (oleic 
acid) indicates more than one double bond, thereby indicating the existence of PUFAs. After peak 
decomposition,  was measured from each spectrum to obtain histograms of the degrees 
of unsaturation of fatty acids in the four groups. The density distribution of  , which 
represents the degree of unsaturation of the fatty acids, is shown in Figure 4.2. Both tumor and 
C H= −
3010 1440/I I C H= −
2CH
3010 1440/I I
3010 1440/I I
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control groups were found to have a unimodal Gaussian-like distribution for  values,  
with significantly different mean values, suggesting a large-scale compositional shift from 
monounsaturated fatty acids to PUFAs in solid tumors. In contrast, a bimodal/trimodal distribution 
was observed in the tumor micro- and macro-environments. The bimodal/trimodal distribution 
reflects the presence of two or three distinct types of fatty acid mixtures that are well-separated in 
space, with one mode similar to that of the control group (mostly monounsaturated fatty acids) and 
the other modes similar to that of the tumor group (larger proportion of PUFAs).  These results 
suggest that a tumor-supportive environment and healthy tissue may differ by only a relatively 
small subset of fatty acids.  
 
Figure 4.2  Density distributions of the level of unsaturation of fatty acids from four different groups (5 rats 
in each group): A. tumor, B. tumor microenvironment, C. tumor macroenvironments, and D. control (no 
treatment group). 
4.2.3   Increased PUFAs in cancerous rats 
For a more intuitive interpretation of , a linear model for predicting the degree of 
unsaturation, was developed based on the measured spectra and known chemical structure from 
reference fatty acids: oleic acid (C18:1) and linoleic acid (C 18:2) (84,85). The average value of 
 was used to predict the average 
2
/C H CHN N= −  for each tissue sample. Figure 4.3 shows 
that tissue samples from tumor-bearing rats exhibited a significantly higher ratio of 
2
/C H CHN N= −  
than those from the control group (mean ± standard deviation: 0.1548 0.0035± ), regardless of 
3010 1440/I I
3010 1440/I I
3010 1440/I I
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whether they were from the solid tumor site (0.1937, no standard deviation is associated with this 
measurement since only one sample was qualified for fatty acid analysis as explained below), 
tumor microenvironment (0.1760 0.0107± ), or tumor macroenvironment (0.1798 0.0088± ). It is 
worth noting that compared with other samples, only one solid tumor sample had a sufficiently 
high concentration of fatty acids for analysis because the Raman signals from the solid tumor areas 
tend to have greater contributions from the cell cytoplasm, cell nucleus, and collagen, but much 
less from fatty acids, which is consistent with what was reported in previous studies (70,75).  
  
Figure 4.3 Quantitative analysis of 
2
/C H CHN N= −  of fatty acids in each tissue sample. The Raman 
measurements of the extracted fatty acids from tissue ( ) were fitted on the linear model to predict 
the molecular structure (
2
/C H CHN N= − ). 
 
 
 
4.2.4   Correlation to the density of cancer cells 
3010 1440/I I
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Since it has been suggested that increased PUFA levels can be positively associated with the 
presence of metastatic cancer cells (52), the possibility that the observed alteration of fatty acid 
composition in the tumor macroenvironment could be due to a local influence resulting from a 
small number of disseminated cancer cells, instead of a global effect of cancer progression, was 
considered. To address this, an evaluation of the correlation between PUFA levels and the 
abundance of cancer cells was needed.  
First, the abundance of cancer cells at different tissue sites was measured. The 787 cm-1 
Raman peak (DNA: O-P-O, cytosine, uracil, thymine (83)), a signature for DNA, cell nuclei, and 
cancerous tissue, was used to quantify the relative concentration of nucleic acids present in the 
tissue (86). As shown in Figure 4.4A, high concentrations of DNA were only observed at the tumor 
sites, which was consistent with many reports of using Raman spectroscopy for tumor 
detection (52,86).  
Next, the effect of the density of cancer cells on the concentration of PUFAs in tissue was 
tested. As shown in Figure 4.4B, the data points representing tissue from cancerous rats mostly lie 
in the upper half of the graph, which corresponds to significantly increased PUFA levels, but 
exhibited no consistent trend in terms of the density of cancer cells. The poor correlation between 
the relative DNA concentration and PUFA accumulation, together with the absence of strong DNA 
bands in the tumor micro- and macroenvironment, demonstrates that the observation of increased 
production of PUFAs is independent from the presence of densely-accumulated cancer cells and 
likely a realistic reflection of more global macroenvironmental changes in lipid metabolism.  
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Figure 4.4 The lack of a strong DNA signal and poor correlation between DNA and PUFA levels in the tumor 
micro- and macroenvironment show that increased PUFA levels are not the consequence of disseminated 
cancer cells in the rat model. One mean DNA concentration value was generated for each specimen and 
grouped in terms of their location and cancer status. A. Scatterplot of relative DNA concentration of different 
tissue sites in rats. B. Correlation plot of relative DNA concentration and the unsaturation degree of fatty 
acids in rats. 
4.2.5   Correlation to the fingerprint region of the Raman spectrum 
As 90% of the spectroscopic Raman information on biological tissue is carried in the 
fingerprint stretching region (from 400 cm-1 to 1800 cm-1), a considerable proportion of the Raman 
instruments have been designed for signal detection in the fingerprint region. Additionally, the 
strong C=C stretch at 1655 cm-1 and the =C-H in-plane deformation at 1267 cm-1 have both been 
shown to indicate the degree of unsaturation in the chain. Thus, it is reasonable to extend our 
spectral analysis from the Raman CH stretching band region (2800-3100 cm-1) to the fingerprint 
vibration region (1200-1800 cm-1). Although the Raman intensity at 1267 cm-1 has been useful in 
studies of unsaturated lipids, it is often obscured by the CH2 stretching band at 1303 cm-1. Thus, 
the C=C stretch at 1655 cm-1 is used as an indicator in the fingerprint region for the quantification 
of the degree of unsaturation of fatty acids.  
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Figure 4.5 shows the analysis of 1655 1440/I I , the ratio of the Raman intensity of the C=C 
stretching vibration to the intensity of the  deformation (84). As expected, results from the 
two spectral ranges in the rat study are strongly correlated and demonstrate a similar trend that the 
primary tumor, the tumor microenvironment, and the tumor macroenvironment have higher PUFA 
levels, compared to the healthy tissue environment. In previous analyses, the Raman CH vibration 
was chosen over the fingerprint vibration region because β-carotene is often found in conjunction 
with fat throughout the human breast (76), and produces strong Raman signals in the fingerprint 
vibration region but not in the CH vibration region (87,88) at the excitation wavelength of 532 nm. 
2CH
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Figure 4.5 Analysis in the fingerprint region also shows increased PUFA levels in the tumor and in the micro- 
and macroenvironments in the rat mammary gland. A. Comparison of average Raman spectra of fatty acids 
from tumor sites, the micro- and macro tumor environments of tumor-bearing rats, and the healthy tissue 
from control rats. B. Raman spectra of two pure reference fatty acid (oleic acid and linoleic acid) in the 
fingerprint region from 1400 cm-1 to 1700 cm-1. C. Quantitative analysis of the unsaturated degree of fatty 
acids from different tissue sites. D. Correlation plot of Raman intensity at 1665 cm-1 and 3010 cm-1 from fatty 
acids of various sites in cancer and control rats. E-H. Density distributions of the degree of unsaturation of 
fatty acids from four different groups (5 rats in each group): tumor, micro- and macroenvironments, and 
control (no treatment group). 
4.3   Discussion 
The data presented here suggests that the primary tumor, tumor microenvironment, and 
tumor macroenvironment from rats induced with NMU have higher PUFA levels, compared with 
the healthy mammary tissue from control rats. However, one should be cautious to draw the 
conclusion that breast cancer development causes increased PUFA levels across the rat mammary 
tissue.   
In 2004, it was reported that the mammary epithelial cells exposed in vitro to NMU went 
through neoplastic transformation when they were injected into a carcinogen-treated stroma but 
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formed phenotypically normal ducts when injected into non-treated stroma (89). Thus, it was 
suggested that the stroma is a crucial target of NMU in rat mammary gland carcinogenesis. Due to 
such direct effects of NMU on the stroma, it is intuitive to question whether the fatty acid content 
alteration observed in the micro- and macroenvironment of NMU-treated rats was directly induced 
by NMU for tumor initiation instead of as a consequence of the mutational event in cancer cells. 
A straightforward way to exclude the effect of NMU is to explore the fatty acid composition in 
natural human breast cancer. Thus, to address this concern, and also to explore the clinical potential 
of our findings, chemical analysis of cancerous human breast tissue was performed. 
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5   Quantification of PUFAs in human breast cancer 
5.1   Study design 
 This study was conducted under a protocol approved by the Institutional Review Boards at 
the University of Illinois at Urbana-Champaign and Carle Foundation Hospital, Urbana, IL. All 
tissue samples were obtained from subjects who preoperatively signed an informed consent 
permitting the investigational use of their tissue. Fresh samples of human breast tissue were 
obtained from Carle Foundation Hospital and the National Development and Research Institutes, 
Inc. (NDRI). Human breast tissue obtained from Carle was acquired following either mastectomy 
or breast reduction surgery, transported in a cold saline solution, and examined ex vivo within 12 
hours of excision. Human breast tissue obtained from NDRI was acquired from breast reduction 
surgery, transported in dry ice, and examined ex vivo within 48 hours of excision. Tissue were 
acquired from a total of 7 female breast cancer subjects, ages 46 through 83, with an average age 
of  60 years, and 6 healthy female subjects, ages 24 through  54, with an average age of 40 years. 
The body mass index (BMI) for cancer patients ranged from 21.2 to 35.4, with an average BMI of 
25.7. For the healthy subjects, the BMI was only available from two of the subjects due to 
procedural problems. The BMI for these two patients was 25 and 38, respectively. More specific 
information about the tissue samples can be found in Table 5.1. 
The data collected from human breast tissue were divided into three groups: cancerous, 
normal appearing, and normal. Cancerous breast tissue samples were obtained from subjects 
undergoing mastectomy and diagnosed by a board-certified pathologist as containing both primary 
tumor and non-tumor tissue that bordered the tumor. Normal appearing breast tissue samples from 
breast cancer subjects were obtained from areas that were at least 5 centimeters away from the 
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removed primary tumor and were identified as normal by pathologists. Normal breast tissue 
samples were obtained from subjects undergoing breast reduction surgery.  
 
Table 5.1. Human breast tissue samples used in this study. 
Human Type Patients  
(n) 
Samples 
(n) 
With Breast 
Cancer 
Breast cancer surgery   
 Cancerous tissue from breast cancer patients 7 52 
 Normal-appearing tissue from breast cancer patients 7 29 
Without 
Breast Cancer 
Breast reduction surgery   
 Normal tissue from cancer-free patients 6 38 
Total  13 119 
 
5.2   Results and discussion 
5.2.1   Spectral signatures of PUFA 
Figure 5.1 shows that the average intensities of the unsaturation band (3010 cm-1) of the fatty 
acids in the tissue samples from the cancer group appear to be stronger than those in the healthy 
group, indicating possibly increased PUFA levels. 
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Figure 5.1 Comparison of average Raman spectra of fatty acids from cancerous and normal-appearing tissue 
of cancer subjects, and from normal tissue of cancer-free subjects. 
5.2.2   Distribution of PUFAs 
Figure 5.2 shows that, consistent with the pre-clinical rat study, both cancerous and healthy 
tissue samples have a unimodal distribution of the degree of unsaturation with different mean 
values, suggesting a large-scale transition from monounsaturated fatty acids to PUFAs at the tumor 
sites and nearby tumor boundaries. In contrast, the group of normal appearing tissue exhibits a 
bimodal pattern in the distribution of the degree of unsaturation of fatty acids, which suggests the 
alteration of a relatively small subset of fatty acids in the tumor macroenvironment of human breast 
cancer.   
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Figure 5.2 Density distributions of the degree of unsaturation of fatty acids from three groups of tissue 
samples: cancerous, normal-appearing, normal. 
5.2.3   Increased PUFAs in cancer subjects 
The next step was to investigate if significantly increased PUFA levels accompany human 
breast cancer. As shown in Figure 5.3, the average value of 
2
/C H CHN N= − 	  of fatty acids from 
healthy breast tissue	  is closest to that of oleic acid (0.1478 0.0048±  vs. 0.1429), which further 
confirms the predominance of monounsaturated fatty acids in healthy human breast tissue (88). 
Consistent with the rat study, cancerous tissues showed a higher value of 
2
/C H CHN N= −  compared 
with normal tissue from cancer-free subjects ( 0.1768 0.0035±  and 0.1478 0.0048± , 
respectively). This observation is in line with previous experimental studies reporting that PUFAs 
have tumor- and metastasis-promoting effects in cultured cells, animals, and human (53,54,56). 
Furthermore, the normal appearing tissues from cancer subjects were found to have significantly 
higher PUFA levels ( 0.1650 0.0058± ) compared with the normal tissues from cancer-free 
subjects, suggesting that the regulation and alteration of lipid metabolism by cancer cells affects 
not only the primary tumor site and its local microenvironment, but also areas in the 
macroenvironment, even a few centimeters away from the primary tumor.  
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Figure 5.3 Quantitative analysis of 
2
/C H CHN N= −  of fatty acids in each tissue sample. 
5.2.4   Correlation to the density of cancer cells 
In order to evaluate the effect of the density of cancer cells on PUFA levels in human breast 
tissue, abundance of cancer cells was measured through the Raman peak at 787 cm-1 and 
correlations between DNA and PUFA levels were tested based on relevant Raman bands. 
Consistent with the pre-clinical study, high concentrations of DNA were only observed at the 
tumor sites, and no strong correlations existed between the DNA abundance and PUFA levels, as 
shown in Figure 5.4. Therefore, the possibility of disseminated cancer cells causing increased 
PUFA levels in human breast cancer can likely be ruled out, lending support to the previous 
hypothesis that increased PUFA levels is a part of the macroenvironmental regulation in breast 
cancer. 
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Figure 5.4 The lack of a strong DNA signal and poor correlation between DNA and PUFA levels in the 
normal appearing tissue show that increased PUFA levels are not the consequence of disseminated cancer 
cells in human breast tissue. One mean DNA concentration value was generated for each specimen and 
grouped in terms of their location and cancer status. A. Scatterplot of relative DNA concentration of different 
tissue sites in human. B. Correlation plot of relative DNA concentration and the unsaturation degree of fatty 
acids in human. 
5.2.5   Correlation to obesity 
Obesity can induce a series of systemic metabolic syndromes, including insulin resistance, 
elevated levels of cholesterol, and promoted inflammation. Although it is a well-known fact that 
obese people have a higher cancer risk and worse prognoses, the complex mechanism underlying 
this obesity-cancer link is poorly understood. A major challenge has been in deciphering which of 
these obesity-induced factors mediates the key risk factors for breast cancer. 
One of the key processes that appear to play a causal role in the obesity-cancer link is 
inflammation. Overweight and obese women showed elevated systemic inflammation in their 
breast tissue (90,91). This could likely be attributed to the increased level of COX-2, which 
catalyzes the synthesis of proinflammatory PGE2 in overweight and obese women (90). There are 
several interesting observations about PGE2. First, although it is counterintuitive, PEG2, the by-
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product of obesity, has been shown to be able to induce COX-2 and thereby increase its own 
production by itself (35). Next, PEG2 is known to promote breast cancer development by 
stimulating the synthesis of estrogen, inhibiting apoptosis, and facilitating migration and invasion. 
Finally, PGE2 is one of the n-6 PUFA derived messengers (35). Given all these facts and 
implications, it is intuitive to hypothesize that obesity is positively associated with elevated levels 
of PUFAs, which likely play an essential role in mediating the synthesis of PGE2, and thereby 
promoting breast cancer. 
As a preliminary experiment, BMI was used as an indicator for obesity and  as an 
indicator for PUFA levels to assess the correlation between these two factors. A positive 
relationship was expected between the PUFA levels in the healthy breast tissue and the BMI of 
that subject. Unfortunately, no conclusion could be drawn from the preliminary results since BMI 
information was only available from two healthy subjects, as shown in Figure 5.5. 
It should be noted, however, that BMI, a parameter based on a person’s body weight and 
height, is not necessarily enough information to scientifically characterize their health risks from 
obesity. It is a little shocking to realize that this parameter has been used for the past two centuries 
since its conception in 1823. Nevertheless, in recent years, there has been considerable debate 
surrounding the use of BMI in defining obesity. In future obesity-cancer studies, it will be desirable 
to include the assessment of other metabolic markers such as fasting blood glucose, total serum 
cholesterol, and circulating lipid levels, in addition to BMI, to better characterize the health risks 
from obesity.  
3010 1440/I I
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Figure 5.5 Scatterplot of PUFA level versus BMI. Each dot represents the average PUFA level and BMI of 
one subject. The color of each dot corresponds to which group they belong, red for cancerous tissue, green 
for normal appearing tissue, and blue for healthy tissue.  
5.3   Discussion 
The increases of PUFA levels in the normal appearing tissue from human subjects and pre-
clinical rat models are in line with reports that have shown the cancer-promoting effects of PUFAs 
in the macroenvironment (24). It is of note that different PUFA families have different effects on 
breast cancer. Indeed, n-6 PUFAs have been shown to promote tumorigenesis via increasing 
circulating estrogenic compounds levels (47), cell proliferation rate (48), and inflammation (49), 
while n-3 PUFAs have been shown to be responsible for suppressing tumor growth by decreasing 
circulating estrogenic compound levels (47), breast cancer cell growth (50), and HER2 
expression (51). These studies support the findings in this thesis research and suggest that the 
majority of the PUFA content investigated here are n-6 PUFAs (52). Nevertheless, further studies 
are needed to confirm this.    
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More specifically, a significantly increased abundance of n-6 linoleic acids at the tumor sites 
has been documented in clinical studies on patients with breast cancer (92). However, the increased 
PUFA levels observed in the tumor micro- and macroenvironment are unexpected and even appear 
contradictory to previous studies that have suggested the variation in fatty acid content between 
the tumor macroenvironment and healthy tissue is negligible (93). According to the distributions 
shown in Figure 4.2 and Figure 5.2, the tumor micro- and macroenvironment and healthy tissue 
only differ by a relatively small subset of fatty acids, compared with the large-scale transition of 
fatty acid content at the tumor sites. Differentiation by analytical methods used in the past may 
have been hindered by the volume averaging effect and relatively low SNR since speed and 
portability are usually prioritized in clinical studies.  
Furthermore, studies on the links between lipid metabolism and breast cancer have been 
largely limited to murine models, mainly because cells involved in adipogenic regulatory networks 
are difficult to obtain and culture for long periods of time (94). Lipid metabolism has been shown 
to differ greatly between human and murine models so one must be cautious to extend the 
observations reported here in murine models to humans (95). Nevertheless, the consistency 
between the pre-clinical rat study and the human study suggests that the NMU-induced rat 
mammary tumor model could be used as a future pre-clinical model for studies involving PUFA 
production in the tumor sites, the microenvironment, and the macroenvironment.  
The data presented in this thesis suggests that breast cancer is not just a localized event 
centered on carcinoma cells in the primary tumor, but rather a more global process involving tissue 
surrounding and even distant from the primary tumor. Our observation of increased PUFA levels 
in the macroenvironment of breast cancer, together with previous reports that have shown the 
positive association between PUFAs and obesity (96), raises the intriguing possibility that 
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increased PUFA levels in the tumor macroenvironment might be one of the biochemical links 
between breast cancer and obesity.   
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6   Conclusion and future direction  
6.1   Conclusion 
Altered lipid metabolism has been extensively investigated in cancer cells (52,56), but not 
in their micro- or macroenvironment. This imbalance of attention is due in part to the belief that 
normal appearing tissue distant from tumor sites could be assumed to be similar to healthy tissue 
and be used as a control group in comparison studies. However, the results reported here suggest 
that subtle but reproducible differences exist in the fatty acid content between healthy tissue from 
cancer-free subjects and normal appearing tissue from cancerous subjects. By optimizing high 
SNR and minimizing the effect of volume averaging of chemicals during Raman data acquisition 
and processing, significantly increased PUFA levels were identified in the tumor, as well as in the 
tumor micro- and macroenvironments in both human tissues and in pre-clinical rat models. These 
data support the concept of micro- and macroenvironmental regulation in mammary tissues of 
humans and rat models with breast carcinoma (20,21,24). These findings are likely to provide new 
insights into the mechanisms of breast cancer development and also suggest potential approaches 
for the assessment of the macroenvironment in human tissues and rat models.  
In addition, this study demonstrates the capability of Raman micro-spectroscopy to identify 
the subtle but reproducible chemical changes in the tumor micro- and macroenvironment in human 
tissues and rat models with breast cancer. Considering the rapid advances in the development of 
portable Raman spectroscopy (64,97) and coherent Raman imaging microscopy (98,99), the 
proposed strategy presented here may help future applications related to intraoperative detection, 
prognosis, and assessment of macroenvironment-targeted therapies. Moreover, as a typical Raman 
spectrometer offers the best performance in either the fingerprint or CH region, the high correlation 
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demonstrated in the fatty acid analysis between these regions gives researchers the freedom to 
choose either vibration band of interest.   
A major limitation of this study is the small number of animals and human tissue specimens 
involved in the statistical analysis. However, it is important to emphasize that the main purpose of 
this study was to propose a new hypothesis in macroenvironmental regulation and an approach for 
detection. To establish the clinical significance of these initial findings, chemical analysis of a 
larger number of samples is needed. Another potential future direction is to correlate PUFA 
abundance with the stage of breast cancer and the percentage of body fat (or BMI) to better 
understand their effects on PUFA production.  
In conclusion, this thesis research demonstrated increased PUFA levels in the tumor, as well 
as in the tumor micro- and macroenvironment of human breast cancer and rat mammary cancer, 
which has important implications for further clarifying the global effect of cancer progression. 
These findings also suggest that there may be high potential for using Raman scattering to 
characterize the tumor micro- and macroenvironment of breast cancer in both pre-clinical animal 
studies and human clinical applications. This could furthermore influence current therapeutic 
approaches for breast cancer and related metabolic diseases. 
6.2   Future direction 
Future work can take many directions in the field of analyzing micro- and 
macroenvironmental alterations in cancer. One of the most important future directions is to 
develop an improved imaging system that has the capability to acquire the compositional, spatial, 
functional, and even temporal information about all major chemical components of tumor and its 
environment simultaneously. In theory, most of such information can be provided by spontaneous 
Raman scattering. However, practically, the intrinsically low signals levels of spontaneous Raman 
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techniques prevent their adoption as popular imaging modalities. One possible solution to this 
problem is coherent Raman imaging (CRI), which provides the same information about molecular 
vibrations but with signal levels that are orders-of-magnitude larger than spontaneous Raman 
scattering (100,101). In addition to CRI, other modalities, including multiphoton fluorescence, and 
second and third harmonic generation, will be incorporated into the same system to provide 
complimentary information about structural or functional changes in biological systems. In 
contrast to CRI, these modalities rely on contrast generated from only one or several specific 
structures or molecules. Despite this limit of contrast, these multiphoton techniques are currently 
much more sensitive and specific than CRI as long as the targeted molecule is active for the applied 
modality. 
The results presented in this thesis encourage further exploration of PUFA levels in the 
tumor and the tumor micro- and macroenvironment in breast cancer. To begin, it is desirable to 
involve more disease types and larger sample sizes in future studies. It will be interesting to 
investigate if there is any correlation between the stage of breast cancer and PUFA levels in the 
normal appearing breast tissue. Additionally, if possible, dietary PUFA input should be tracked 
and even controlled for every subject in future studies, as it has been shown that fatty acid 
composition of adipose tissue depends heavily on dietary input (36). Furthermore, future studies 
should consider the correlation between PUFA abundance and obesity. This could provide insights 
into the mechanisms linking breast cancer and obesity.  
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